Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

April 16, 2020

Study Completion Date

April 16, 2020

Conditions
Depressive Disorder, Major
Interventions
DRUG

Vortioxetine

Target dose is 10 mg/day; the dose can be down- or uptitrated to 5, 15, or 20 mg/day.

Trial Locations (31)

Unknown

"MHAT Targovishte AD", Targovishte

DCC Mladost-M, Varna

Marienthal Center of Psychiatry and Psychology, Tallinn

CHU de Nantes - Hopital Hotel Dieu, Nantes

Rheinhessen-Fachklinik Mainz, Kinder und Jugendpsychiatri, Mainz

Vadaskert Alapitvany, Budapest

Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula

Scientific Institute Fondazione Stella Maris, Calambrone

Universita degli Studi di Messina - Facolta di Medicina e Chirurgia, Messina

Linda Keruze's Psychiatric Center, LLC, Liepāja

Prywatne Gabinety Lekarskie ¿Promedicus¿ Anna Agnieszka Tomczak, Bialystok

Centrum Badan Klinicznych PI-House Sp. z o.o., Gdansk

Przychodnia Syntonia Poradnia Zdrowia Psychicznego, Kielce

SPECTRUM Centrum Neurologii i Psychiatrii, Lublin

Filip Rybakowski Specjalistyczna Praktyka Lekarska, Poznan

"Samodzielny Publiczny Zaklad Opieki Zdrowotnej (SPZOZ) - Centrum Neuropsychiatrii NEUROMED", Wroclaw

Specialized Clinical Psychiatric Hospital 1 of the Ministry of Health, Krasnodar

Lipetsk Regional Psychoneurological Hospital, Lipetsk

Nizhny Novgorod Region State Institution Of Healthcare, Nizhny Novgorod

"Medicorehabilitation Research Center Phoenix", Rostov-on-Don

Rostov State Medical University of the Minzdravsotsrazvitiya of Russia, Rostov-on-Don

"Guz Saratov Regional Psychiatric Hospital St. Sofii", Saratov

Saratov State Medical University, Saratov

State Budgetary Healthcare Institution, Tonnel'nyy

State Budgetary Healthcare Institution of Sverdlovsk Region, Yekaterinburg

Clinic of Neurology and Psychiatry for Children and Adolescents, Belgrade

Clinical Center of Vojvodina - Clinic of Psychiatry, Novi Sad

Cape Trial Centre, Bellville

Hospital General Universitario Gregorio Maranon, Madrid

Unidad de Salud Mental Infanto-Juvenil (USMI-J) Edificio de Consultas Externas. Hospital MarAtimo, Torremolinos

Alder Hey Childrens Hospital, Liverpool

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT03108625 - Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age | Biotech Hunter | Biotech Hunter